Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. [electronic resource]
Producer: 19990210Description: 73-80 p. digitalISSN:- 0009-7322
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anticoagulants -- adverse effects
- Female
- Germany -- epidemiology
- Hemorrhage -- epidemiology
- Heparin -- adverse effects
- Hirudin Therapy
- Hirudins -- adverse effects
- Humans
- Incidence
- Male
- Middle Aged
- Prospective Studies
- Recombinant Proteins -- adverse effects
- Retrospective Studies
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.